Cornerstone Enterprises LLC Raises Holdings in Omega Healthcare Investors, Inc. $OHI

Cornerstone Enterprises LLC lifted its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 37.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 186,758 shares of the real estate investment trust’s stock after purchasing an additional 50,928 shares during the quarter. Omega Healthcare Investors comprises approximately 3.7% of Cornerstone Enterprises LLC’s holdings, making the stock its 9th largest position. Cornerstone Enterprises LLC owned 0.06% of Omega Healthcare Investors worth $6,845,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in OHI. NBC Securities Inc. bought a new stake in shares of Omega Healthcare Investors in the 1st quarter worth approximately $29,000. MassMutual Private Wealth & Trust FSB boosted its position in shares of Omega Healthcare Investors by 562.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust’s stock worth $67,000 after purchasing an additional 1,552 shares in the last quarter. Register Financial Advisors LLC bought a new position in Omega Healthcare Investors in the 2nd quarter valued at approximately $73,000. UMB Bank n.a. lifted its position in Omega Healthcare Investors by 94.9% in the 1st quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust’s stock valued at $83,000 after acquiring an additional 1,059 shares in the last quarter. Finally, Trust Co. of Vermont bought a new position in Omega Healthcare Investors in the 2nd quarter valued at approximately $95,000. 65.25% of the stock is owned by institutional investors.

Omega Healthcare Investors Price Performance

Shares of Omega Healthcare Investors stock opened at $40.67 on Thursday. Omega Healthcare Investors, Inc. has a one year low of $35.04 and a one year high of $44.42. The stock’s fifty day moving average is $41.55 and its 200 day moving average is $38.77. The stock has a market cap of $12.00 billion, a P/E ratio of 25.10, a P/E/G ratio of 1.91 and a beta of 0.70. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10.

Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.32. The company had revenue of $235.60 million for the quarter, compared to analysts’ expectations of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.Omega Healthcare Investors’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period last year, the firm earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Sell-side analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were issued a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.6%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 165.43%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on OHI. Scotiabank upped their price objective on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a research report on Thursday, August 28th. Mizuho upped their price objective on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research report on Thursday, September 11th. Royal Bank Of Canada upped their price objective on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a “sector perform” rating in a research report on Thursday, August 7th. Cantor Fitzgerald started coverage on Omega Healthcare Investors in a research report on Wednesday, October 1st. They issued an “overweight” rating and a $50.00 price objective on the stock. Finally, Wells Fargo & Company increased their price target on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an “overweight” rating in a report on Wednesday, August 27th. Seven investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $44.44.

Insider Buying and Selling

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the sale, the director directly owned 18,654 shares of the company’s stock, valued at $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.50% of the stock is currently owned by corporate insiders.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.